This page includes the latest FDA filings for Avanir Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Avanir Pharmaceuticals, Inc., Patheon, Patheon Inc. | Prescription Medication | 2023-12-08 |
| Avanir Pharmaceuticals, Inc., Patheon, Patheon Inc. | Prescription Medication | 2022-11-04 |
| Avanir Pharmaceuticals, Inc., Patheon, Patheon Inc. | Prescription Medication | 2020-12-18 |
| Avanir Pharmaceuticals, Inc., PTI Royston LLC, UPM Pharmaceuticals | Prescription Medication | 2020-01-30 |
| Avanir Pharmaceuticals, Inc., Patheon, Patheon Inc. | Prescription Medication | 2019-10-24 |
| Avanir Pharmaceuticals, Inc., PTI Royston LLC, UPM Pharmaceuticals | Prescription Medication | 2017-12-12 |
| Avanir Pharmaceuticals, Inc. | ONZETRA | 2015-10-01 |
| Avanir Pharmaceuticals, Inc. | NUEDEXTA | 2010-12-01 |
| NCAGE Code | 479A4 | AVANIR PHARMACEUTICALS, INC. |
| CAGE Code | 479A4 | AVANIR PHARMACEUTICALS, INC. |
| S.A.M. Registration | 479A4 [198413080] | AVANIR PHARMACEUTICALS, INC. |
| DUNS | 198413080 | Avanir Pharmaceuticals, Inc. |
| SEC | 0000858803 | AVANIR PHARMACEUTICALS, INC. of DELAWARE |